id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1237-0007,FDA,FDA-2012-E-1237,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-03-10T04:00:00Z,2015,3,2015-03-10T04:00:00Z,,2015-03-10T14:41:47Z,,0,0,0900006481a382ba
FDA-2012-E-1237-0006,FDA,FDA-2012-E-1237,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PERJETA",Notice,General Notice,2014-05-19T04:00:00Z,2014,5,2014-05-19T04:00:00Z,,2014-05-19T14:26:52Z,2014-11515,0,0,0900006481703551
FDA-2012-E-1237-0005,FDA,FDA-2012-E-1237,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-05-02T04:00:00Z,2014,5,2014-05-02T04:00:00Z,,2014-05-02T19:17:01Z,,0,0,09000064816de8fc
FDA-2012-E-1237-0004,FDA,FDA-2012-E-1237,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-30T04:00:00Z,2014,3,2014-03-30T04:00:00Z,,2014-03-30T04:05:37Z,,0,0,090000648168f914
FDA-2012-E-1237-0003,FDA,FDA-2012-E-1237,FDA/CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2013-02-04T05:00:00Z,2013,2,2013-02-04T05:00:00Z,,2013-02-04T20:01:09Z,,0,0,09000064811e57fd
FDA-2012-E-1237-0001,FDA,FDA-2012-E-1237,"Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T16:13:29Z,,0,0,090000648119df04
FDA-2012-E-1237-0002,FDA,FDA-2012-E-1237,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T16:13:31Z,,0,0,090000648119e02b